Enviado: 19/2/2013 19:37...
Sector
Healthcare
Biotechnology / Pharmaceuticals
Biotechnology / Pharmaceuticals
Biotechnology
Business Summary
ThromboGenics specializes in the research and development of bio-therapeutic products for treating cardiovascular diseases, ophthalmic disorders, and cancers. Net sales break down by source of income as follows:
- sales of licenses (96.9%);
- royalties (1.8%);
- other (1.3%).
4-traders.com